Surgery
Volume 146, Issue 2 , Pages 166-173 , August 2009

Allospecific CD154+ T cells identify rejection-prone recipients after pediatric small-bowel transplantation

,Accepted 6 April 2009.

References 

  1. Abu-Elmagd K, Reyes JR, Bond G, Mazariegos G, Wu T, Murase N, et al. Clinical intestinal transplantation: a decade of single center experience. Ann Surg. 2001;234:404–416discussion 416-7
  2. Bond GJ, Mazariegos GV, Sindhi R, Abu-Elmagd KM, Reyes J. Evolutionary experience with immunosuppression in pediatric intestinal transplantation. J Pediatr Surg. 2005;40:274–279discussion 279-80
  3. Reyes J, Mazariegos GV, Abu-Elmagd K, Macedo C, Bond GJ, Murase N, et al. Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin). Am J Transplant. 2005;5:1430–1436
  4. Kerman RH, Susskind B, Katz SM, Van Buren CT, Kahan BD. Postrenal transplant MLR hypo-responders have fewer rejections and better graft survival than MLR hyper-responders. Transplant Proc. 1997;29:1410–1411
  5. Sindhi R, Magill A, Abdullah A, Seward J, Tresgaskes M, Bentlejewski C, et al. Enhanced donor-specific alloreactivity occurs independent of immunosuppression in children with early liver allograft rejection. Am J Transplant. 2005;5:96–102
  6. Khera N, Janosky J, Zeevi A, Mazariegos G, Marcos A, Sindhi R. Persistent donor-specific alloreactivity may portend delayed liver rejection during drug minimization in children. Front Biosci. 2007;1:660–663
  7. Gebauer BS, Hricik DE, Atallah A, Bryan K, Riley J, Tary-Lehmann M, et al. Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplant. 2002;2:857–866
  8. Ashokumar C, Talukdar A, Sun Q, Higgs BW, Janosky J, Wilson P, et al. Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation. Am J Transplant. 2009;9:179–191
  9. Schönbeck U, Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci. 2001;58:4–43
  10. Iwakoshi NN, Mordes JP, Markees TG, Phillips NE, Rossini AA, Greiner DL. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner. J Immunol. 2000;164:512–521
  11. Dai Z, Lakkis FG. The role of cytokines, CTLA-4 and costimulation in transplant tolerance and rejection. Curr Opin Immunol. 1999;11:504–508
  12. Issazadeh S, Navikas V, Schaub M, Sayegh M, Khoury S. Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J Immunol. 1998;161:1104–1112
  13. Im SH, Barchan D, Maiti PK, Fuchs S, Souroujon MC. Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4. J Immunol. 2001;166:6893–6898
  14. Chattopadhyay PK, Yu J, Roederer M. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nat Med. 2005;11:1113–1117
  15. Frentsch M, Arbach O, Kirchhoff D, Moewes B, Worm M, Rothe M, et al. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat Med. 2005;11:1118–1124
  16. Hosmer D, Lemeshow S. Applied logistic regression. 2nd ed. New York: Wiley; 2000;
  17. Nagelkerke NJD. A note on a general definition of the coefficient of determination. Biometrika. 1991;78:691–692
  18. Bautista D, Arana E, Martí-Bonmatí L, Paredes R. Validation of logistic regression models in small samples: application to calvarial lesions diagnosis. J Clin Epidemiol. 1999;52:237–241
  19. Fawcett T. An introduction to ROC analysis. Pattern Recogn Lett. 2006;27:861–874
  20. Taguchi O, Kontani K, Ikeda H, Kezuka T, Takeuchi M, Takahashi T, et al. Tissue-specific suppressor T cells involved in self-tolerance are activated extrathymically by self-antigens. Immunology. 1994;82:365–369

 Supported in part by research grants from the Children's Hospital Research Foundation (to R.S.).

PII: S0039-6060(09)00232-3

doi: 10.1016/j.surg.2009.04.006

Surgery
Volume 146, Issue 2 , Pages 166-173 , August 2009